03 September 2018
: Case report
Agranulocytosis Induced by Vancomycin. Case Report and Literature Review
Unusual or unexpected effect of treatment, Adverse events of drug therapy
Horacio di Fonzo1ABCDEFG*, Melina Villegas Gutsch1BDF, Augusto Castroagudin1BF, María Victoria Cabrera1BF, Mariano E. Mazzei1ADF, Darío Rueda1ABDEFDOI: 10.12659/AJCR.909956
Am J Case Rep 2018; 19:1053-1056
Abstract
BACKGROUND: Vancomycin has been used for decades to treat infections by Gram-positive bacteria, particularly those caused by methicillin-resistant staphylococci. Agranulocytosis is an infrequent complication of this antibiotic, postulated in its genesis a mechanism immune-mediated by antineutrophil antibodies and antineutrophil cytoplasm antibodies (ANCA). Treatment includes discontinuing vancomycin, and granulocyte colony-stimulating factor administration.
CASE REPORT: We present the case of a patient who developed agranulocytosis secondary to vancomycin during the treatment of an infectious endocarditis, which was reversed when the antibiotic was stopped. Concomitantly to neutropenia, he had ANCA positivity, which subsequently became negative.
CONCLUSIONS: Agranulocytosis induced by vancomycin is infrequent and generally occurs after day 12 of treatment. In most cases, like in our case, it is caused by an immune-mediated mechanism. More studies are needed to determine the pathogenic mechanism and the ANCA role in this adverse effect.
Keywords: agranulocytosis, Antibodies, Antineutrophil Cytoplasmic, Vancomycin
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947938
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947163
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949194
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948731
Most Viewed Current Articles
21 Jun 2024 : Case report
101,839
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
54,458
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
38,088
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
25,936
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200